ACMI - Accumed Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ACMI - Accumed Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Frank Buck who wrote (686)	12/17/1997 11:18:00 PM
From: Sigmund	Read Replies (2) of 1894

I don't know what the situation is re NeoPath being able to read Thin Prep slides but I don't think it is germane re FDA approval for NeoPath. A class of slides that can not be read but which can be identified in advance would I assume simply not be screened on the NeoPath device and not rejected for manual screening. This could impact the economics of the device if there were a high percentage of Thin Prep slides but I don't see how it would be a safety issue. Am I missing something? I am not currently an investor in ACMI (but considering it) and I am an investor in NeoPath.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next